https://www.selleckchem.com/pr....oducts/Dihydroartemi
Six interventions were aimed at improving knowledge, decision-making and health behaviours, but evidence for their effectiveness was weak. Study heterogeneity, low quality and focus on kidney failure largely impede the identification of intervention targets and strategies for LHL. More and higher quality studies in earlier CKD stages are needed to unravel how LHL leads to worse health outcomes, and to identify targets and strategies to prevent disease deterioration. Healthcare organizations need to develop and evaluate e
Like
Comment
Share
